Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.
Titolo: | Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients |
Autori: | |
Data di pubblicazione: | 2017 |
Rivista: | |
Abstract: | Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester. |
Handle: | http://hdl.handle.net/11379/496615 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.